Zobrazeno 1 - 10
of 68
pro vyhledávání: '"J P, Buyniski"'
Autor:
J. P. Buyniski, J. S. Gidda
Publikováno v:
American Journal of Physiology-Gastrointestinal and Liver Physiology. 251:G779-G785
This study examined the role of cholinergic mechanisms in esophageal smooth muscle of anesthetized opossums. Swallow-induced motility was recorded manometrically before and after treatment with physostigmine or metoclopramide. At the 5-cm site above
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f10da0e7e70897c36479fedb7639877
https://doi.org/10.1152/ajpgi.1986.251.6.g779
https://doi.org/10.1152/ajpgi.1986.251.6.g779
Autor:
J. S. Fleming, J. P. Buyniski
Publikováno v:
Cardiovascular Drug Reviews. 1:277-294
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc6c00ce8292644ea0658fc12bc54693
https://doi.org/10.1111/j.1527-3466.1983.tb00452.x
https://doi.org/10.1111/j.1527-3466.1983.tb00452.x
Publikováno v:
Clinical and Experimental Hypertension. 2:1039-1066
Subcutaneous administration of tiodazosin (0.1-3 mg/kg), prazosin (0.01-1 mg/kg), trimazosin (10-30 mg/kg) and phentolamine (0.1-3 mg/kg) to conscious spontaneously hypertensive rats (SHR) produced graded decreases in blood pressure with the order of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b30feed3dac5a8a261886ef8ed2ef4e3
https://doi.org/10.3109/10641968009037160
https://doi.org/10.3109/10641968009037160
Publikováno v:
Research communications in chemical pathology and pharmacology. 23(1)
Cisplatin (cis-diammine-dichloro-platinum) administered at a dose of 3 mg/kg iv induced a reproducible and characteristic emetic response in the dog. It was characterized by a latency period (90-120 min) and multiple emetic episodes occuring within 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6527fa2a3578fb6ba166413651a077cd
https://pubmed.ncbi.nlm.nih.gov/441517
https://pubmed.ncbi.nlm.nih.gov/441517
Autor:
J. S. Fleming, J. P. Buyniski
Publikováno v:
VIth International Congress on Thrombosis and Haemostasis.
A potent, new anti-thrombotic agent, 6 ,7-dichloro-l,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-one hydrochloride monohydrate (BL-4162A) has been evaluated for activity against induced platelet aggregation in a series of in vitro and ex vivo experime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76cd66a6d483494dee6bbff1068e7529
https://doi.org/10.1055/s-0039-1680489
https://doi.org/10.1055/s-0039-1680489
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 243(3)
Histamine H2 receptor antagonists have been reported to protect the gastric mucosa of animals and humans against aspirin-induced damage. It is unclear, however, whether this protective effect can be observed at doses less than those needed to markedl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e761986f4f14d0b9f961a37991e39427
https://pubmed.ncbi.nlm.nih.gov/2891837
https://pubmed.ncbi.nlm.nih.gov/2891837
Publikováno v:
Archives internationales de pharmacodynamie et de therapie. 235(1)
Isobolographic analysis was used to study in mice the combined oral analgetic action of butorphanol, a new centrally acting analgetic, and acetaminophen, an antipyretic analgetic. Combinations of butorphanol-acetaminophen exhibited analgetic effects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fa4f15bcd66d6a5bb974f4d45c1eb4fe
https://pubmed.ncbi.nlm.nih.gov/736686
https://pubmed.ncbi.nlm.nih.gov/736686
Publikováno v:
Research communications in chemical pathology and pharmacology. 23(1)
Prazosin produces a "first-dose" phenomenon in man clinically characterized by an exaggerated hypotensive response to the initial dose of the drug, with subsequent doses not producing this exaggerated effect. In spontaneously hypertensive rats (SHR),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6e2faf6f0541ddb6bf92ab96a7d11f61
https://pubmed.ncbi.nlm.nih.gov/441514
https://pubmed.ncbi.nlm.nih.gov/441514
Autor:
J. P. Buyniski, R. L. Cavanagh
Publikováno v:
Alimentary pharmacologytherapeutics. 3(3)
BMY-25368, 1-amino-2-[3-(3-piperidinomethylphenoxy) propylamino]-1-cyclobutene-3,4-dione, a new histamine H2-receptor antagonist, has been compared to ranitidine as an inhibitor of gastric acid secretion in the Heidenhain pouch dog. Intravenous infus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27fde1fb5926a4e33016536090d8912c
https://pubmed.ncbi.nlm.nih.gov/2577694
https://pubmed.ncbi.nlm.nih.gov/2577694
Publikováno v:
Archives internationales de pharmacodynamie et de therapie. 233(2)
Butorphanol, levo-N-cyclobutylmethyl-3, 14beta-dihydroxy-morphinan, is a new agonist-antagonist type analgetic agent which is 4 times more potent than morphine in experimental animals. Equianalgetic doses of butorphanol and morphine were compared, fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b499fcfbc93df736d41d34b389860011
https://pubmed.ncbi.nlm.nih.gov/686916
https://pubmed.ncbi.nlm.nih.gov/686916